These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2154920)

  • 61. A prospective comparison of DNA quantitation by image and flow cytometry.
    Bauer TW; Tubbs RR; Edinger MG; Suit PF; Gephardt GN; Levin HS
    Am J Clin Pathol; 1990 Mar; 93(3):322-6. PubMed ID: 2155525
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Correlation of numerically detected microcalcifications on the mammogram and in this manner diagnosed carcinomas and mastopathies].
    Menges V; Wellauer J; Engeler V; Stadelmann R
    Radiologe; 1973 Nov; 13(11):468-76. PubMed ID: 4360451
    [No Abstract]   [Full Text] [Related]  

  • 63. [Correlations between receptor state and various clinico-morphological parameters: evaluation of circa 2000 cases of breast tumors].
    Lampertico P; Stagni F
    Pathologica; 1985; 77(1049):281-97. PubMed ID: 3008068
    [No Abstract]   [Full Text] [Related]  

  • 64. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation.
    Verkooijen HM;
    Int J Cancer; 2002 Jun; 99(6):853-9. PubMed ID: 12115488
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Age-related differences in patients with nonpalpable breast carcinomas.
    Wazer DE; Gage I; Homer MJ; Krosnick SH; Schmid C
    Cancer; 1996 Oct; 78(7):1432-7. PubMed ID: 8839548
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Not all nonpalpable breast cancers are alike.
    Franceschi D; Crowe JP; Lie S; Duchesneau R; Zollinger R; Shenk R; Stefanek G; Shuck JM
    Arch Surg; 1991 Aug; 126(8):967-70; discussion 970-1. PubMed ID: 1650548
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Screening mammography following autologous breast reconstruction: an unnecessary effort.
    Freyvogel M; Padia S; Larson K; Dietz J; Grobmyer S; O'Rourke C; Valente S
    Ann Surg Oncol; 2014 Oct; 21(10):3256-60. PubMed ID: 25059787
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases.
    Fallenius AG; Franzén SA; Auer GU
    Cancer; 1988 Aug; 62(3):521-30. PubMed ID: 3390793
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Laser flow cytofluorometry as a supplementary method of determining the degree of tumor differentiation in breast cancer patients].
    Bogatyrev VN; Ermilova VD; Petrova AS
    Arkh Patol; 1986; 48(1):44-8. PubMed ID: 2421692
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mammographically detected breast cancer. Nonpalpable is not a synonym for inconsequential.
    Schwartz GF; Carter DL; Conant EF; Gannon FH; Finkel GC; Feig SA
    Cancer; 1994 Mar; 73(6):1660-5. PubMed ID: 8156493
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of mammographically obvious carcinomas of the breast with benign results upon initial biopsy.
    Meyer JE; Kopans DB
    Surg Gynecol Obstet; 1981 Oct; 153(4):570-2. PubMed ID: 6269239
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of malignancy potential in so-called interval mammary carcinomas.
    von Rosen A; Erhardt K; Hellström L; Somell A; Auer G
    Breast Cancer Res Treat; 1985; 6(3):221-7. PubMed ID: 3004621
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison between slide and flow cytophotometric DNA measurements in breast tumors.
    Auer GU; Askensten U; Erhardt K; Fallenius A; Zetterberg A
    Anal Quant Cytol Histol; 1987 May; 9(2):138-46. PubMed ID: 3606774
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tamoxifen binding sites in human mammary cancers.
    Fujino N; Kimura M; Sakamoto K; Shigaki N; Yamashita J; Akagi M
    Jpn J Surg; 1986 Sep; 16(5):311-7. PubMed ID: 3025494
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A comparative morphometric and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast.
    Norris HJ; Bahr GF; Mikel UV
    Anal Quant Cytol Histol; 1988 Feb; 10(1):1-9. PubMed ID: 2833287
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful?
    Daroles J; Borget I; Suciu V; Mazouni C; Delaloge S; Balleyguier C
    Eur J Cancer; 2017 Nov; 85():23-30. PubMed ID: 28881248
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.
    McCarty KS; Barton TK; Fetter BF; Woodard BH; Mossler JA; Reeves W; Daly J; Wilkinson WE; McCarty KS
    Cancer; 1980 Dec; 46(12 Suppl):2851-8. PubMed ID: 6256054
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nonpalpable breast cancer: a mammographic-histological correlation.
    Egense M; Brünner S; Hansen H; Jacobsen GK; Laursen N
    Recent Results Cancer Res; 1990; 119():116-21. PubMed ID: 2173081
    [No Abstract]   [Full Text] [Related]  

  • 79. The diagnostic value of xero-mammography in clinically occult breast carcinoma.
    Kambouris T; Kotoulas K; Pontifex G
    Radiologe; 1984 May; 24(5):230-4. PubMed ID: 6087403
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fine needle aspiration of breast carcinoma: a preliminary cytoprognostic study.
    Mouriquand J; Pasquier D
    Acta Cytol; 1980; 24(2):153-9. PubMed ID: 6245554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.